Teladoc Health Files 8-K on Financials
Ticker: TDOC · Form: 8-K · Filed: Jul 29, 2025 · CIK: 1477449
| Field | Detail |
|---|---|
| Company | Teladoc Health, Inc. (TDOC) |
| Form Type | 8-K |
| Filed Date | Jul 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: TDOC
TL;DR
TDOC filed an 8-K on 7/29/25 detailing financial results. Check it out.
AI Summary
Teladoc Health, Inc. filed an 8-K on July 29, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to the company's performance. The report is filed under the 1934 Securities Exchange Act.
Why It Matters
This 8-K filing provides crucial updates on Teladoc Health's financial performance and operational results, which can impact investor decisions and market perception.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate or significant new risks.
Key Players & Entities
- Teladoc Health, Inc. (company) — Registrant
- July 29, 2025 (date) — Date of Report
- 1934 Act (legal_document) — SEC Act
- 001-37477 (legal_document) — SEC File Number
- 04-3705970 (tax_id) — I.R.S. Employer Identification No.
- 155 E 44th Street Floor 17 (address) — Principal executive offices
- New York, NY 10017 (address) — Principal executive offices
- 2036352002 (phone_number) — Registrant's telephone number
FAQ
What specific financial information is being reported in this 8-K?
The 8-K filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K report filed?
The report was filed on July 29, 2025.
What is the exact name of the company filing this report?
The exact name of the registrant is Teladoc Health, Inc.
Under which section of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the company's principal executive office address?
The principal executive offices are located at 155 E 44th Street Floor 17, New York, NY 10017.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 29, 2025 regarding Teladoc Health, Inc. (TDOC).